Data from Glycomine’s Ongoing Natural History Study Provides Insight into Clinical Measures and Biomarkers for PMM2-CDG

SAN CARLOS, Calif.–(BUSINESS WIRE)– #CDG–Data from Ongoing Natural History Study Provides Insight into Clinical Measures and Biomarkers for PMM2-CDG
Click here to view original post